Breast Cancer - ILD Diagnosis and Management in TDx Treatment

This case study discusses the diagnosis and management of a 58-year-old male patient with HER2 breast cancer, highlighting the use of trastuzumab deruxtecan and steroid treatment for managing liver metastases and interstitial lung disease.

Target Audience

Healthcare Professionals

Learning Objectives

  • Recognize common side effects associated with CDK4/6 inhibitors, such as neutropenia and gastrointestinal symptoms, and their potential impact on quality of life.
  • Develop proactive management plans, including dose adjustments and patient education, to mitigate side effects and support patient adherence.
  • Recognize the main strategies to manage the adverse effects associated with CDK4/6 inhibitors.

This activity is supported by an educational grant from Eli Lilly.

Course summary

Course opens: 
09/08/2026
Course expires: 
09/30/2031
Cost:
$0.00
Rating: 
0
Prof. Giuseppe Curigliano

Prof. Giuseppe Curigliano

Professor of Medical Oncology at University of Milan, Italy

Price

Cost:
$0.00
Please login or register to take this course.